Centene Corporation’s CNC Medicare brand, Wellcare, announced expansion endeavors for growth of its Medicare Advantage (MA) and Medicare Prescription Drug Plan (PDP) in 2024. Next year, Centene aims ...
Centene (NYSE:CNC) has decided to stop paying commissions to brokers and agents who help people obtain the company’s Medicare prescription drug plans starting next year, Stat News reported Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback